<?xml version="1.0" encoding="UTF-8"?>
<html><body class="spl" id="spl">
<div class="DocumentTitle"><p class="DocumentTitle"><strong>DEXTROSE AND SODIUM CHLORIDE- dextrose and sodium chloride injection, solution </strong><br>B. Braun Medical Inc.<br></p></div>
<h1><span class="Bold">Dextrose and Sodium Chloride Injection USP</span></h1>
<div class="Contents">
<div class="Section" data-sectionCode="48780-1">
<a name="section-1"></a><p></p>
</div>
<div class="Section" data-sectionCode="34089-3">
<a name="LINK_fb5a6a7e-242c-4049-a40b-61449bbfc419"></a><a name="section-1"></a><p></p>
<h1>DESCRIPTION</h1>
<p class="First">Each 100 mL of 5% Dextrose and 0.45% Sodium Chloride Injection USP contains: Hydrous Dextrose USP 5 g; Sodium Chloride USP 0.45 g; Water for Injection USP qs</p>
<p>pH: 4.4 (3.5-6.5)</p>
<p>Calculated Osmolarity: 406 mOsmol/liter, hypertonic</p>
<p>Concentration of Electrolytes (mEq/liter):  Sodium 77       Chloride 77</p>
<p>5% Dextrose and 0.45% Sodium Chloride Injection USP is sterile, nonpyrogenic and contains no bacteriostatic or antimicrobial agents. This product is intended for intravenous administration.</p>
<p>The formulas of the active ingredients are:</p>
<table>
<col>
<col>
<col>
<tbody class="Headless">
<tr class="First">
<td align="center" valign="top">
<span class="Bold">Ingredients</span> </td>
<td align="center" valign="top">
<span class="Bold">Molecular Formula</span> </td>
<td align="center" valign="top"> <span class="Bold">Molecular Weight</span>
</td>
</tr>
<tr>
<td align="center" valign="top"> Sodium Chloride USP</td>
<td align="center" valign="top"> NaCI</td>
<td align="center" valign="top"> 58.44</td>
</tr>
<tr class="Last">
<td align="center" valign="top"> Hydrous Dextrose USP</td>
<td align="center" valign="top"> <img alt="Dextrose Molecule" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=7949edf6-3afd-48cb-9f02-5136d69f9e27&amp;name=dextrose-and-sodium-chloride-injection-in-e3-1.jpg">
</td>
<td align="center" valign="top"> 198.17</td>
</tr>
</tbody>
</table>
<p>Not made with natural rubber latex, DEHP, or PVC.</p>
<p>The plastic container is made from a homogenous blend of polypropylene and thermoplastic modifier specifically developed for parenteral drugs. The container is nontoxic and biologically inert. The container is a closed system and is not dependent upon entry of external air during administration. </p>
<p>Addition of medication should be accomplished using complete aseptic technique.</p>
<p>The closure system has two ports; the one for the administration set and the other is a medication addition site. Each port has a tamper evident cover. Refer to the Directions for Use of the container.</p>
</div>
<div class="Section" data-sectionCode="34090-1">
<a name="LINK_137d99ae-d713-4464-ba18-7ffbcfd3b5b0"></a><a name="section-2"></a><p></p>
<h1>CLINICAL PHARMACOLOGY</h1>
<p class="First">5% Dextrose and 0.45% Sodium Chloride Injection USP provides electrolytes and calories and is a source of water for hydration. It is capable of inducing <span class="product-label-link" type="condition" conceptid="79936" conceptname="Polyuria">diuresis</span> depending on the clinical condition of the patient.</p>
<p>Sodium, the major cation of the extracellular fluid, functions primarily in the control of water distribution, fluid balance, and osmotic pressure of body fluids. Sodium is also associated with chloride and <span class="product-label-link" type="condition" conceptid="4285456" conceptname="Bicarbonate">bicarbonate</span> in the regulation of the acid-base equilibrium of body fluid.</p>
<p>Chloride, the major extracellular anion, closely follows the metabolism of sodium, and changes in the acid-base balance of the body are reflected by changes in the chloride concentration.</p>
<p>Dextrose provides a source of calories. Dextrose is readily metabolized, may decrease losses of body protein and nitrogen, promotes glycogen deposition and decreases or prevents <span class="product-label-link" type="condition" conceptid="4101761" conceptname="Ketosis">ketosis</span> if sufficient doses are provided.</p>
</div>
<div class="Section" data-sectionCode="34067-9">
<a name="LINK_4982f96f-9dda-4a1a-b67d-bdb97ab4213e"></a><a name="section-3"></a><p></p>
<h1>INDICATIONS AND USAGE</h1>
<p class="First">This intravenous solution is indicated for use in adults and pediatric patients as a source of electrolytes, calories and water for hydration.</p>
</div>
<div class="Section" data-sectionCode="34070-3">
<a name="LINK_3e23aeb3-6b17-40f2-8742-ac9fef373de2"></a><a name="section-4"></a><p></p>
<h1>CONTRAINDICATIONS</h1>
<p class="First">This solution is contraindicated where the administration of sodium or chloride could be clinically detrimental.</p>
<p>Solutions containing dextrose may be contraindicated in patients with <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">hypersensitivity</span> to corn products.</p>
</div>
<div class="Section" data-sectionCode="34071-1">
<a name="LINK_3ef0ec64-d535-42c5-99c1-df1ba44986b4"></a><a name="section-5"></a><p></p>
<h1>WARNINGS</h1>
<p class="First">The administration of intravenous solutions can cause fluid and/or solute overload resulting in dilution of serum electrolyte concentrations, <span class="product-label-link" type="condition" conceptid="4266976" conceptname="Overhydration">overhydration</span>, congested states or <span class="product-label-link" type="condition" conceptid="4078925" conceptname="Pulmonary edema">pulmonary edema</span>. The risk of dilutional states is inversely proportional to the electrolyte concentration. The risk of solute overload causing congested states with peripheral and <span class="product-label-link" type="condition" conceptid="4078925" conceptname="Pulmonary edema">pulmonary edema</span> is directly proportional to the electrolyte concentration.</p>
<p>Solutions containing sodium ions should be used with great care, if at all, in patients with <span class="product-label-link" type="condition" conceptid="319835" conceptname="Congestive heart failure">congestive heart failure</span>, severe <span class="product-label-link" type="condition" conceptid="192359" conceptname="Renal failure syndrome">renal insufficiency</span>, and in clinical states in which there is <span class="product-label-link" type="condition" conceptid="4190305" conceptname="Hypernatremia">sodium retention</span> with <span class="product-label-link" type="condition" conceptid="433595" conceptname="Edema">edema</span>. In patients with diminished renal function, administration of solutions containing sodium ions may result in <span class="product-label-link" type="condition" conceptid="4190305" conceptname="Hypernatremia">sodium retention</span>.</p>
<p>Excessive administration of potassium-free dextrose solutions may result in significant <span class="product-label-link" type="condition" conceptid="437833" conceptname="Hypokalemia">hypokalemia</span>. Serum potassium levels should be maintained and potassium supplemented as required.</p>
<p>Solutions containing dextrose and low electrolyte concentrations should not be administered simultaneously with blood through the same infusion set because of the possibility of pseudoagglutination or <span class="product-label-link" type="condition" conceptid="4126829" conceptname="Hemolysis">hemolysis</span>.</p>
</div>
<div class="Section" data-sectionCode="42232-9">
<a name="LINK_9b6088ca-9be5-414c-b564-6a25bb1ed1d4"></a><a name="section-6"></a><p></p>
<h1>PRECAUTIONS</h1>
<div class="Section" data-sectionCode="34072-9">
<a name="LINK_f2c55481-c2f5-4af7-9428-f40c66d1ca74"></a><a name="section-6.1"></a><p></p>
<h2>General</h2>
<p class="First">This solution should be used with care in patients with <span class="product-label-link" type="condition" conceptid="434004" conceptname="Hypervolemia">hypervolemia</span>, <span class="product-label-link" type="condition" conceptid="192359" conceptname="Renal failure syndrome">renal insufficiency</span>, <span class="product-label-link" type="condition" conceptid="194406" conceptname="Urinary tract obstruction">urinary tract obstruction</span>, or impending or frank cardiac decompensation.</p>
<p>Extraordinary electrolyte losses such as may occur during protracted nasogastric suction, <span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">vomiting</span>, <span class="product-label-link" type="condition" conceptid="80141" conceptname="Functional diarrhea">diarrhea</span> or <span class="product-label-link" type="condition" conceptid="4295370" conceptname="Gastrointestinal fistula">gastrointestinal fistula</span> drainage may necessitate additional electrolyte supplementation.</p>
<p>Additional essential electrolytes, minerals and vitamins should be supplied as needed.</p>
<p>Sodium-containing solutions should be administered with caution to patients receiving corticosteroids or corticotropin, or to other salt-retaining patients. Care should be exercised in administering solutions containing sodium to patients with renal or cardiovascular insufficiency, with or without <span class="product-label-link" type="condition" conceptid="319835" conceptname="Congestive heart failure">congestive heart failure</span>, particularly if they are postoperative or elderly.</p>
<p>Solutions containing dextrose should be used with caution in patients with overt or known <span class="product-label-link" type="condition" conceptid="44808385" conceptname="Pre-diabetes">subclinical diabetes</span> mellitus, or carbohydrate intolerance for any reason.</p>
<p><span class="product-label-link" type="condition" conceptid="437833" conceptname="Hypokalemia">Hypokalemia</span> may develop during parenteral administration of hypertonic dextrose solutions. Sufficient amounts of potassium should be added to dextrose solutions administered to fasting patients with good renal function, especially those on digitalis therapy.</p>
<p>To minimize the risk of possible incompatibilities arising from mixing this solution with other additives that may be prescribed, the final infusate should be inspected for cloudiness or precipitation immediately after mixing, prior to administration and periodically during administration.</p>
<p>Do not use plastic container in series connection.</p>
<p>If administration is controlled by a pumping device, care must be taken to discontinue pumping action before the container runs dry or <span class="product-label-link" type="condition" conceptid="4156949" conceptname="Air embolism">air embolism</span> may result.</p>
<p>This solution is intended for intravenous administration using sterile equipment. It is recommended that intravenous administration apparatus be replaced at least once every 24 hours.</p>
<p>Use only if solution is clear and container and seals are intact.</p>
</div>
<div class="Section" data-sectionCode="34075-2">
<a name="LINK_62237fd3-6e80-43b8-b81c-abcd8d631f1e"></a><a name="section-6.2"></a><p></p>
<h2>Laboratory Tests</h2>
<p class="First">Clinical evaluation and periodic laboratory determinations are necessary to monitor changes in fluid balance, electrolyte concentrations, and acid-base balance during prolonged parenteral therapy or whenever the condition of the patient warrants such evaluation. Significant deviations from normal concentrations may require tailoring of the electrolyte pattern, in these or alternative solutions.</p>
</div>
<div class="Section" data-sectionCode="34083-6">
<a name="LINK_38d53e0d-7c5b-4056-b9dc-4c68200eaaed"></a><a name="section-6.3"></a><p></p>
<h2>Carcinogenesis, Mutagenesis, Impairment of Fertility</h2>
<p class="First">Studies with 5% Dextrose and 0.45% Sodium Chloride Injection USP have not been performed to evaluate carcinogenic potential, mutagenic potential, or effects on fertility.</p>
</div>
<div class="Section" data-sectionCode="42228-7">
<a name="LINK_d6bf89c1-03d7-4673-9a10-290207ac8734"></a><a name="section-6.4"></a><p></p>
<h2>Pregnancy</h2>
<div class="Section" data-sectionCode="34077-8">
<a name="LINK_b14ca2f0-9ec5-4bca-ad43-e24b05731787"></a><a name="section-6.4.1"></a><p></p>
<h3>Teratogenic Effects</h3>
<p class="First">Pregnancy Category C. Animal reproduction studies have not been conducted with 5% Dextrose and 0.45% Sodium Chloride Injection USP. It is also not known whether 5% Dextrose and 0.45% Sodium Chloride Injection USP can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. 5% Dextrose and 0.45% Sodium Chloride Injection USP should be given to a pregnant woman only if clearly needed.</p>
</div>
</div>
<div class="Section" data-sectionCode="34079-4">
<a name="LINK_fb09f0c8-3f8a-4b7d-8ce6-3a939444c8a0"></a><a name="section-6.5"></a><p></p>
<h2>Labor and Delivery</h2>
<p class="First">The effects of 5% Dextrose and 0.45% Sodium Chloride Injection USP on the duration of labor or delivery, on the possibility that forceps delivery or other intervention or resuscitation of the newborn will be necessary, and on the later growth, development, and functional maturation of the child are unknown.</p>
<p>As reported in the literature, sodium and dextrose containing solutions have been administered during labor and delivery. Caution should be exercised, and the fluid balance, glucose and electrolyte concentrations, and acid-base balance, of both mother and fetus should be evaluated periodically or whenever warranted by the condition of the patient or fetus.</p>
</div>
<div class="Section" data-sectionCode="34080-2">
<a name="LINK_8a8586ac-b964-493a-a476-873aeeb35a37"></a><a name="section-6.6"></a><p></p>
<h2>Nursing Mothers</h2>
<p class="First">It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when 5% Dextrose and 0.45% Sodium Chloride Injection USP is administered to a nursing woman.</p>
</div>
<div class="Section" data-sectionCode="34081-0">
<a name="LINK_18aeec53-a6ea-4e7b-89b7-6380972dce01"></a><a name="section-6.7"></a><p></p>
<h2>Pediatric Use</h2>
<p class="First">Safety and effectiveness of 5% Dextrose and 0.45% Sodium Chloride Injection USP in pediatric patients have not been established by adequate and well-controlled studies.</p>
<p>Dextrose is safe and effective for the stated indications in pediatric patients (see <span class="Bold"><a href="#LINK_4982f96f-9dda-4a1a-b67d-bdb97ab4213e">INDICATIONS AND USAGE</a></span>). As reported in the literature, the dosage selection and constant infusion rate of intravenous dextrose must be selected with caution in pediatric patients, particularly neonates and low birth weight infants, because of the increased risk of <span class="product-label-link" type="condition" conceptid="4214376" conceptname="Hyperglycemia">hyperglycemia</span>/<span class="product-label-link" type="condition" conceptid="24609" conceptname="Hypoglycemia">hypoglycemia</span>. Frequent monitoring of serum glucose concentrations is required when dextrose is prescribed to pediatric patients, particularly neonates and low birth weight infants.</p>
<p>In neonates or in very small infants even small volumes of fluid may affect fluid and electrolyte balance. Care must be exercised in treatment of neonates, especially pre-term neonates, whose renal function may be immature and whose ability to excrete fluid and solute loads may be limited. Fluid intake, urine output, and serum electrolytes should be monitored closely. See <span class="Bold"><a href="#LINK_3ef0ec64-d535-42c5-99c1-df1ba44986b4">WARNINGS</a></span> and <span class="Bold"><a href="#LINK_96c1dfaf-ee7b-4cda-8a16-33ce5a467413">DOSAGE AND ADMINISTRATION</a></span>.</p>
</div>
<div class="Section" data-sectionCode="34082-8">
<a name="LINK_e5a86bde-66c2-4782-a3ba-c257c5e9fcb7"></a><a name="section-6.8"></a><p></p>
<h2>Geriatric Use</h2>
<p class="First">Clinical studies of 5% Dextrose and 0.45% Sodium Chloride Injection USP did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects. Other reported clinical experience has not identified differences in responses between elderly and younger patients.</p>
<p>In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy.</p>
<p>This drug is known to be substantially excreted by the kidney, and the risk of toxic reactions to this drug may be greater in patients with <span class="product-label-link" type="condition" conceptid="4030518" conceptname="Renal impairment">impaired renal function</span>. Because elderly patients are more likely to have decreased renal function, care should be taken in dose selection, and it may be useful to monitor renal function.</p>
<p>See <span class="Bold"><a href="#LINK_3ef0ec64-d535-42c5-99c1-df1ba44986b4">WARNINGS</a></span>.</p>
</div>
</div>
<div class="Section" data-sectionCode="34084-4">
<a name="LINK_0bf2112e-4fe8-4425-8d5a-01b2fca1f8a5"></a><a name="section-7"></a><p></p>
<h1>ADVERSE REACTIONS</h1>
<p class="First">Reactions which may occur because of the solution or the technique of administration include febrile response, <span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">infection</span> at the site of injection, <span class="product-label-link" type="condition" conceptid="444247" conceptname="Venous thrombosis">venous thrombosis</span> or <span class="product-label-link" type="condition" conceptid="318174" conceptname="Phlebitis">phlebitis</span> extending from the site of injection, <span class="product-label-link" type="condition" conceptid="4295895" conceptname="Extravasation">extravasation</span> and <span class="product-label-link" type="condition" conceptid="434004" conceptname="Hypervolemia">hypervolemia</span>.</p>
<p>Too rapid infusion of hypertonic solutions may cause local <span class="product-label-link" type="condition" conceptid="4329041" conceptname="Pain">pain</span> and venous irritation. Rate of administration should be adjusted according to tolerance. Use of the largest peripheral vein and a small bore needle is recommended. (See <span class="Bold"><a href="#LINK_96c1dfaf-ee7b-4cda-8a16-33ce5a467413">DOSAGE AND ADMINISTRATION</a></span>.)</p>
<p>Symptoms may result from an excess or deficit of one or more of the ions present in the solution; therefore, frequent monitoring of electrolyte levels is essential.</p>
<p><span class="product-label-link" type="condition" conceptid="4190305" conceptname="Hypernatremia">Hypernatremia</span> may be associated with <span class="product-label-link" type="condition" conceptid="433595" conceptname="Edema">edema</span> and exacerbation of <span class="product-label-link" type="condition" conceptid="319835" conceptname="Congestive heart failure">congestive heart failure</span> due to the retention of water, resulting in an expanded extracellular fluid volume.</p>
<p>If infused in large amounts, chloride ions may cause a loss of <span class="product-label-link" type="condition" conceptid="4285456" conceptname="Bicarbonate">bicarbonate</span> ions, resulting in an acidifying effect.</p>
<p>The physician should also be alert to the possibility of adverse reactions to drug additives diluted and administered from the plastic container. Prescribing information for drug additives to be administered in this manner should be consulted.</p>
<p>If an adverse reaction does occur, discontinue the infusion, evaluate the patient, institute appropriate therapeutic countermeasures, and save the remainder of the fluid for examination if deemed necessary.</p>
</div>
<div class="Section" data-sectionCode="34088-5">
<a name="LINK_01adae12-3df7-4cc8-8b7e-c39845632832"></a><a name="section-8"></a><p></p>
<h1>OVERDOSAGE</h1>
<p class="First">In the event of a fluid or solute overload during parenteral therapy, reevaluate the patient’s condition and institute appropriate corrective treatment.</p>
</div>
<div class="Section" data-sectionCode="34068-7">
<a name="LINK_96c1dfaf-ee7b-4cda-8a16-33ce5a467413"></a><a name="section-9"></a><p></p>
<h1>DOSAGE AND ADMINISTRATION</h1>
<p class="First">This solution is for intravenous use only.</p>
<p>Dosage is to be directed by a physician and is dependent upon age, weight, clinical condition of the patient and laboratory determinations. Frequent laboratory determinations and clinical evaluation are essential to monitor changes in blood glucose and electrolyte concentrations, and fluid and electrolyte balance during prolonged parenteral therapy.</p>
<p>When a hypertonic solution is to be administered peripherally, it should be slowly infused through a small bore needle, placed well within the lumen of a large vein to minimize venous irritation. Carefully avoid infiltration.</p>
<p>Fluid administration should be based on calculated maintenance or replacement fluid requirements for each patient.</p>
<p>Some additives may be incompatible. Consult with pharmacist. When introducing additives, use aseptic techniques. Mix thoroughly. Do not store.</p>
<p>Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit.</p>
<div class="Section" data-sectionCode="34081-0">
<a name="LINK_b8a509b0-9201-49a4-9a84-096e3f1f817f"></a><a name="section-9.1"></a><p></p>
<h2>Pediatric Use</h2>
<p class="First">There is no specific pediatric dose. The dose is dependent on weight, clinical condition, and laboratory results. See <span class="Bold"><a href="#LINK_3ef0ec64-d535-42c5-99c1-df1ba44986b4">WARNINGS</a></span> and <span class="Bold"><a href="#LINK_9b6088ca-9be5-414c-b564-6a25bb1ed1d4">PRECAUTIONS</a></span>.</p>
</div>
</div>
<div class="Section" data-sectionCode="34069-5">
<a name="LINK_3e914197-ce5d-4ad3-88c1-1ca52ca9d16d"></a><a name="section-10"></a><p></p>
<h1>HOW SUPPLIED</h1>
<p class="First">5% Dextrose and 0.45% Sodium Chloride Injection USP is supplied sterile and nonpyrogenic in Plastic Containers. The 1000 mL containers are packaged 12 per case.</p>
<table>
<col>
<col>
<col>
<tbody class="Headless">
<tr class="First">
<td align="center" valign="top"> <span class="Bold">NDC</span>
</td>
<td align="center" valign="top"> <span class="Bold">REF</span>
</td>
<td align="right" valign="top"> <span class="Bold">Size</span>
</td>
</tr>
<tr class="Last">
<td align="center" valign="top"> 0264-8612-00</td>
<td align="center" valign="top"> E6120</td>
<td align="right" valign="top"> 1000 mL</td>
</tr>
</tbody>
</table>
<p>Exposure of pharmaceutical products to heat should be minimized. Avoid excessive heat. Protect from freezing. It is recommended that the product be stored at room temperature (25°C); however, brief exposure up to 40°C does not adversely affect the product.</p>
</div>
<div class="Section" data-sectionCode="59845-8">
<a name="LINK_5d434adf-2ea0-4c7f-88a7-49c3c112cb3d"></a><a name="section-11"></a><p></p>
<h1>Directions for Use of Plastic Container</h1>
<p class="First"><span class="Bold">Caution:</span> Do not use plastic container in series connection.</p>
<p><span class="Bold">To Open</span></p>
<p>Check for minute leaks by squeezing solution container firmly. If leaks are found, discard solution as <span class="product-label-link" type="condition" conceptid="4035976" conceptname="Sterility">sterility</span> may be impaired. If supplemental medication is desired, follow directions below before preparing for administration.</p>
<p><span class="Bold">NOTE:</span>    Before use, perform the following checks:</p>
<ul class="Disk">
<li>Inspect each container. Read the label. Ensure solution is the one ordered and is within the expiration date.
</li>
<li>Invert container and carefully inspect the solution in good light for cloudiness, haze, or particulate matter. Any container which is suspect should not be used.
</li>
<li> Use only if solution is clear and container and seals are intact.</li>
</ul>
<p><span class="Bold">Preparation for Administration</span></p>
<ol class="Arabic">
<li>Remove plastic protector from sterile set port at bottom of container.</li>
<li>Attach administration set. Refer to complete directions accompanying set.</li>
</ol>
<p><span class="Bold">To Add Medication</span></p>
<p><span class="Bold">Warning:</span> Some additives may be incompatible.</p>
<p><span class="Bold">To Add Medication Before Solution Administration</span></p>
<ol class="Arabic">
<li>Prepare medication site. Remove additive port closure and swab exposed medication site.</li>
<li>Using syringe with 18-22 Ga. needle, puncture medication port and inner diaphragm and inject.</li>
<li>Squeeze and tap ports while ports are upright and mix solution and medication thoroughly.</li>
</ol>
<p><span class="Bold">To Add Medication During Solution Administration</span></p>
<ol class="Arabic">
<li>Close clamp on the set.</li>
<li>Prepare medication site. Remove additive port closure and swab exposed medication site.</li>
<li>Using syringe with 18-22 Ga. needle of appropriate length (at least 5/8 inch), puncture resealable medication port and inner diaphragm and inject.</li>
<li>Remove container from IV pole and/or turn to an upright position.</li>
<li>Evacuate both ports by tapping and squeezing them while container is in the upright position.</li>
<li>Mix solution and medication thoroughly.</li>
<li>Return container to in use position and continue administration.</li>
</ol>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="LINK_f24fe09a-1871-4e4b-a2a8-d4fdeebeb2be"></a><a name="section-12"></a><p></p>
<h1></h1>
<p class="First"><span class="Bold">B. Braun Medical Inc.<br></span>Irvine, CA 92614-5895 USA<br>1-800-227-2862<br>www.bbraun.com</p>
<p>Made in USA</p>
<p>Rx only</p>
<p>Package Insert</p>
<p>Y36-002-836     LD-437-1</p>
<p>Initiated: May 2013</p>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="LINK_447d3c2e-2c98-4e94-9ed3-b260b96fc7d5"></a><a name="section-13"></a><p></p>
<h1>PRINCIPAL DISPLAY PANEL</h1>
<p class="First"><span class="Bold">5% Dextrose and 0.45% Sodium Chloride Injection USP</span></p>
<p>REF  E6120</p>
<p>NDC  0264-8612-00</p>
<p><span class="Bold">1000 mL</span></p>
<p>Each 100 mL contains:</p>
<p>Hydrous Dextrose USP 5 g</p>
<p>Sodium Chloride USP 0.45 g</p>
<p>Water for Injection USP qs</p>
<p>Hypertonic</p>
<p>Electrolytes (mEq/liter):  Na<span class="Sup">+</span>  77     Cl<span class="Sup">–</span>  77</p>
<p>Sterile. Single dose container.</p>
<p>For intravenous use only.</p>
<p><span class="Bold">WARNINGS:</span> Some additives may be incompatible. Consult with pharmacist. When introducing additives, use aseptic techniques. Mix thoroughly. Do not store. Do not administer simultaneously with blood.</p>
<p>Recommended Storage:<br>Room temperature (25°C). Avoid excessive heat. Protect from freezing. See Package Insert.</p>
<p>Not made with natural rubber latex, DEHP, or PVC.</p>
<p>Rx only</p>
<div class="Figure"><img alt="Recycle Symbol" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=7949edf6-3afd-48cb-9f02-5136d69f9e27&amp;name=dextrose-and-sodium-chloride-injection-in-e3-2.jpg"></div>
<p><span class="Bold">B. Braun Medical Inc.<br></span>Irvine, CA 92614-5895 USA<br>1-800-227-2862<br>www.bbraun.com<br>Made in USA</p>
<p>Y38-000-027     LD-405-3</p>
<p>Exp.          Lot</p>
<p><span class="Bold">ADD            SET</span></p>
<div class="Figure"><img alt="Container Label" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=7949edf6-3afd-48cb-9f02-5136d69f9e27&amp;name=dextrose-and-sodium-chloride-injection-in-e3-3.jpg"></div>
</div>
</div>
<div class="DataElementsTables">
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>DEXTROSE AND SODIUM CHLORIDE 		
					</strong><br><span class="contentTableReg">dextrose and sodium chloride injection, solution</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">HUMAN PRESCRIPTION DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:0264-8612</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">INTRAVENOUS</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">    
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>DEXTROSE</strong> (DEXTROSE) </td>
<td class="formItem">DEXTROSE</td>
<td class="formItem">5 g  in 100 mL</td>
</tr>
<tr class="formTableRow">
<td class="formItem">
<strong>SODIUM CHLORIDE</strong> (SODIUM CATION and CHLORIDE ION) </td>
<td class="formItem">SODIUM CHLORIDE</td>
<td class="formItem">0.45 g  in 100 mL</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="2" class="formHeadingTitle">Inactive Ingredients</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>WATER</strong></td>
<td class="formItem"> </td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:0264-8612-00</td>
<td class="formItem">12  in 1 CASE</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem"></td>
<td class="formItem">1000 mL in 1 CONTAINER</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">NDA</td>
<td class="formItem">NDA019631</td>
<td class="formItem">01/31/2014</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
</tbody></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Labeler - </span>B. Braun Medical Inc.
							(002397347)
						</td></tr></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Establishment</span></td></tr>
<tr>
<th scope="col" class="formTitle">Name</th>
<th scope="col" class="formTitle">Address</th>
<th scope="col" class="formTitle">ID/FEI</th>
<th scope="col" class="formTitle">Business Operations</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">B. Braun Medical Inc.</td>
<td class="formItem"></td>
<td class="formItem">037425308</td>
<td class="formItem">LABEL(0264-8612), MANUFACTURE(0264-8612), PACK(0264-8612)</td>
</tr>
</table>
</div>
<p><div class="EffectiveDate">Revised: 1/2014<div class="DocumentMetadata">
<div>
<a href="javascript:toggleMixin();">Document Id: </a>c04b2b6e-1162-4011-a351-a5b95af57643</div>
<div>Set id: 7949edf6-3afd-48cb-9f02-5136d69f9e27</div>
<div>Version: 9</div>
<div>Effective Time: 20140131</div>
</div>
</div> <div class="DistributorName">B. Braun Medical Inc.</div></p>
</body></html>
